US 11739086
Substituted pyrrolopyridine JAK inhibitors and methods of making and using the same
granted A61KA61K31/437A61K31/4545
Quick answer
US patent 11739086 (Substituted pyrrolopyridine JAK inhibitors and methods of making and using the same) held by Aclaris Therapeutics, Inc. expires Mon Aug 24 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Aclaris Therapeutics, Inc.
- Grant date
- Tue Aug 29 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 24 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 5
- CPC classes
- A61K, A61K31/437, A61K31/4545, A61K45/06, A61P